structur
flexibl
small
size
aptam
enabl
precis
recognit
cellular
element
imag
therapeut
applic
process
aptam
taken
cell
depend
target
typic
clathrinmedi
endocytosi
macropinocytosi
intern
aptam
transport
endosom
lysosom
endoplasm
reticulum
golgi
apparatu
occasion
mitochondria
autophagosom
intracellular
aptam
intram
versatil
function
rang
intracellular
rna
imag
gene
regul
therapeut
alloster
modul
discuss
review
immun
respons
therapeut
aptam
effect
gquadruplex
structur
aptam
function
also
discuss
aptam
fold
nucleic
acid
molecul
bind
specif
target
mimick
antibodi
aptam
exist
natur
ligandbind
element
gener
vitro
tailor
specif
purpos
aptam
great
advantag
structur
flexibl
stabil
high
affin
specif
compar
smaller
size
nm
antibodi
nm
allow
bind
dens
cellular
epitop
live
cell
epitop
nativ
fold
demonstr
true
valu
aptam
lie
superior
target
recognit
aptam
show
better
structur
recognit
intracellular
epitop
quickli
emerg
intracellular
target
agent
intracellular
imag
tool
review
discuss
uptak
mechan
subcellular
local
intracellular
imag
therapeut
applic
aptam
human
diseas
also
highlight
specif
exampl
conform
select
aptam
emerg
new
field
along
futur
strategi
facilit
translat
intracellular
aptam
aptam
develop
cell
surfac
receptor
target
deliveri
howev
far
studi
investig
endocyt
mechan
aptam
possibl
endocyt
mechan
numer
well
defin
pathway
aptam
intern
surfac
cell
membran
clathrinand
caveolaemedi
endocytosi
macropinocytosi
phagocytosi
uptak
aptam
mainli
depend
function
target
receptor
base
publish
studi
mechan
intern
aptam
divid
clathrindepend
independ
investig
clathrindepend
pathway
aptam
coloc
studi
mainli
use
fluoresc
label
transferrin
endocyt
pathway
transferrin
receptor
well
character
via
clathrin
mediat
endocytosi
repres
aptam
intern
via
clathrindepend
endocytosi
burkett
lymphoma
cellspecif
dna
aptam
antiprotein
tyrosin
kinas
aptam
fig
clathrindepend
endocytosi
confirm
fluoresc
label
transferrin
investig
clathrinindepend
endocyt
pathway
aptam
inhibitor
intern
use
studi
exampl
clathrinindepend
pathway
aptam
well
character
gquadruplex
nucleolin
dna
aptam
bound
nucleolin
select
express
cancer
plasma
membran
intern
cell
elucid
endocyt
mechan
prostat
cancer
cell
pretreat
cytochalasin
actin
polymer
inhibitor
dynasor
dynamin
inhibitor
clathrinmedi
endocytosi
depend
actin
dynamin
function
wherea
macropinocytosi
phagocytosi
follow
pretreat
uptak
slightli
decreas
suggest
intern
via
clathrinmedi
endocytosi
interestingli
pretreat
amilorid
aml
macropinocytosi
inhibitor
significantli
reduc
uptak
cancer
cell
coloc
macropinocyt
marker
dextran
confirm
confoc
microscopi
show
consist
result
chemic
inhibitor
therefor
seem
predominantli
intern
cancer
cell
via
macropinocytosi
separ
anoth
studi
endocyt
pathway
investig
differ
prostat
cancer
cell
prostat
cancer
cell
pretreat
aml
chlorpromazin
cpz
clathrinmedi
endocytosi
inhibitor
genistein
gen
caveolaeand
lipid
raftmedi
endocytosi
inhibitor
uptak
significantli
inhibit
aml
cpz
neither
complet
prevent
aptam
intern
suggest
mix
clathrinmedi
endocytosi
micropinocytosi
use
endocytosi
contrari
gen
effect
uptak
demonstr
caveolaeand
lipid
raftmedi
endocytosi
involv
endocytosi
taken
togeth
two
studi
indic
intern
nucleolin
aptam
follow
standard
pathway
also
suggest
uptak
mechan
may
vari
type
cancer
cell
fig
receptormedi
endocytosi
aptamerreceptor
complex
fuse
earli
endosom
either
sort
recycl
back
plasma
membran
deliv
late
endosom
lysosom
degrad
know
fate
intern
aptam
cell
subcellular
distribut
aptam
investig
variou
vitro
system
fluoresc
confoc
microscopi
transmiss
electron
microscopi
tem
use
antibodi
nanoparticl
fluoresc
confoc
microscopi
subcellular
distribut
intern
aptam
character
four
studi
coloc
cell
type
specificdna
aptam
late
endosom
lysosom
marker
confirm
renal
proxim
tubul
cell
situ
fluoresc
hybrid
gliomaspecif
dna
aptam
bound
ku
ku
found
coloc
lysosom
endoplasm
reticulum
er
golgi
apparatu
organellespecif
fluoresc
dye
live
cell
imag
confoc
microscopi
prp
c
dna
aptam
conjug
fluoresc
quantum
dot
qd
fluoresc
nanoparticl
track
dynam
intracellular
imag
prp
c
aptamerqd
complex
coloc
lysosom
er
golgi
apparatu
immunofluoresc
assay
rna
aptam
human
papillomaviru
found
endosom
lysosom
autophagosom
er
immunostain
fluoresc
confoc
microscopi
conjug
nanoparticl
np
aptam
use
directli
observ
subcellular
local
aptam
optic
microscopi
tem
without
fluoresc
tag
nucleolin
dna
aptam
conjug
np
subcellular
locat
determin
tem
brain
glial
tumor
cell
brain
endotheli
cell
aptam
mainli
coloc
endosom
mitochondria
cell
local
aptam
lysosom
golgi
apparatu
bind
aptam
receptor
initi
format
clathrinco
pit
follow
clathrinco
vesicl
bud
detach
membran
clathrin
coat
disassembl
clathrindepend
endocytosi
end
fusion
endosom
lysosom
b
uptak
mechan
endocytosi
involv
multipl
pathway
although
macropinocytosi
predomin
endocytosi
mechan
clathrinand
caveolaedepend
clathrinand
caveolaeindepend
pathway
involv
uptak
observ
cell
cell
suggest
subcellular
local
aptam
vari
depend
type
cell
antitranscript
factor
activ
dna
aptam
tag
superparamagnet
iron
oxid
np
gold
np
tem
studi
show
aptam
local
er
cellular
compart
brain
tissu
sampl
taken
togeth
fate
intern
aptam
end
endocyt
vesicl
endosom
lysosom
redistribut
subcellular
compart
depend
physiolog
host
cell
fig
intern
aptam
redistribut
subcellular
organel
remain
investig
major
aptam
antagonist
target
protein
biolog
inhibitori
effect
wellinvestig
howev
physicochem
interact
protein
studi
yet
herein
one
compel
studi
perform
inhibit
physic
movement
target
cell
antinucleolin
aptam
nucleolin
multifunct
shuttl
protein
present
nucleoli
cytoplasm
plasma
membran
bind
partner
protein
arginin
methyltransferas
free
bind
static
complex
distribut
nuclear
cytoplasm
compart
howev
bind
static
complex
decreas
nucleu
increas
cytoplasm
prostat
cancer
cell
suggest
shuttl
function
nucleolin
might
affect
aptam
live
cell
imag
valuabl
studi
function
regul
intracellular
rna
recent
develop
rna
imag
strategi
use
aptam
spinach
broccoli
mango
activ
fluoresc
upon
bind
target
small
molecul
fluorophor
fluorogen
aptam
provid
power
tool
investig
dynam
rna
local
traffick
cell
fluorogen
aptam
great
potenti
simpl
proteinfre
live
cell
imag
detail
fluorogen
aptam
applic
depict
section
first
fluorogen
rna
aptam
spinach
capabl
turn
fluoresc
isol
upon
bind
smallmolecul
fluorophor
imidazolinon
dfhbi
mimick
green
fluoresc
protein
gfp
spinach
show
cross
fluorogen
activ
variant
dfhbi
dfhbi
dfhbi
molecular
structur
analysi
use
biochem
probe
secondari
structur
predict
algorithm
spinach
predict
fold
fiveway
helic
junction
reveal
mechan
fluoresc
activ
spinach
crystal
spinachdfhbi
complex
determin
cocryst
structur
spinachdfhbi
reveal
unexpect
structur
compos
quadruplex
core
flank
two
coaxiallystack
aform
duplex
typic
gquadruplex
contain
guanin
tetrad
howev
quadruplex
element
spinach
exhibit
unconvent
complex
connect
two
gtetrad
mixedbas
tetrad
fluorophor
sandwich
base
tripl
hem
unpair
guanin
residu
comparison
crystal
structur
dfhbifre
spinach
overal
conform
aptam
unchang
fluorophor
bind
site
collaps
rearrang
base
tier
quadruplex
extrud
helic
stack
spinach
show
thermal
instabl
misfold
result
reduc
bright
new
variant
spinach
ispinch
babi
spinach
engin
overcom
shortcom
studi
dfhbi
fluorophor
exhibit
nonspecif
fluoresc
cytotox
cell
feasibl
spinach
test
vivo
imag
spinach
engin
geneticallyencod
tag
cellular
metabolit
second
messeng
cyclic
diamp
cdia
fluoresc
imag
cellular
metabolit
rnabas
sensor
compris
five
ligand
adenosin
adenosin
diphosph
adp
aadenosyllmethionin
sam
guanin
guanosin
gtp
bind
rna
aptam
spinach
via
stem
sequenc
function
transduc
engin
adenosin
adp
sam
guanin
gtpspinach
sensor
show
increas
fluoresc
upon
bind
cognat
ligand
respect
show
rapid
fluoresc
activ
deactiv
kinet
monitor
metabol
dynam
live
escherichia
coli
e
coli
imag
samspinach
sensor
use
dfhbitreat
e
coli
express
samspinach
sensor
show
increas
fold
h
presenc
sam
precursor
methionin
similarli
adpspinach
sensor
also
detect
dynam
chang
adp
level
increas
fluoresc
upon
metabolit
bind
e
coli
visual
intracellular
cdia
level
live
listeria
monocytogen
l
monocytogen
fluoresc
biosensor
combin
ligandsens
domain
cdia
riboswitch
yuaa
riboswitch
term
engin
test
function
fluoresc
biosensor
live
cell
plasmid
encod
biosensor
trna
scaffold
transform
l
monocytogen
result
cellular
fluoresc
observ
fluoresc
microscopi
flow
cytometri
incub
dfhbi
biosensor
tag
spinach
spinach
show
better
imag
live
e
coli
l
monocytogen
cell
anoth
green
fluorogen
rna
aptam
broccoli
bind
fluorophor
dfhbi
also
isol
group
develop
spinach
broccoli
isol
use
combin
method
systemat
evolut
ligand
exponenti
enrich
selex
fluorescenceactiv
cell
sort
fac
approach
selex
perform
first
round
rna
pool
exhibit
fluoresc
upon
incub
fluorophor
aptam
librari
clone
bacteri
express
plasmid
librari
plasmid
transform
e
coli
vivo
fluoresc
sort
fac
presenc
dfhbi
characterist
broccoli
show
robust
fold
low
magnesium
concentr
well
increas
thermost
fluoresc
broccoli
engin
tbroccoli
nt
dimer
tbroccoli
tdbroccoli
vivo
applic
inde
tdbroccoli
show
twice
fluoresc
broccoli
live
e
coli
genet
express
structur
rna
trnafus
scaffold
system
often
use
promot
appropri
fold
aptam
cell
appropri
structur
fold
aptam
pivot
function
aptam
stabl
fold
aptam
tbroccoli
tdbroccoli
fuse
terminu
express
trna
scaffold
plasmid
imag
mammalian
cell
show
brighter
mean
fluoresc
intens
transfect
cell
moreov
broccoli
dbroccoli
fuse
terminu
without
trna
scaffold
plasmid
show
higher
cellular
bright
fuse
trna
scaffoldaptam
construct
cell
support
idea
trna
scaffold
select
necessari
depend
fold
effici
aptam
genet
tag
imag
rna
aptam
mango
bind
deriv
fluorophor
thiazol
orang
develop
seri
fluorogen
aptam
molecular
structur
analysi
use
sequenc
analys
biochem
probe
mango
predict
fold
twotier
allparallel
gquadruplex
connect
aform
duplex
reveal
mechan
fluoresc
activ
mango
crystal
complex
determin
cocryst
structur
reveal
threetier
gquadruplex
includ
three
antiparallel
quinin
residu
connect
aform
duplex
gaaa
tetralooplik
junction
fluorophor
bound
one
flat
face
gquadruplex
stabil
mangoto
bind
fluoresc
therefor
mango
enhanc
fluoresc
fluorophor
rel
unbound
fluorophor
mango
show
brightest
fluoresc
among
spinach
broccoli
fluorogen
aptam
feasibl
vivo
imag
determin
caenorhabd
elegan
c
elegan
visual
cellular
rna
mango
directli
inject
c
elegan
syncyti
gonad
either
without
rna
mango
inject
dye
alon
show
neglig
fluoresc
inject
mango
result
strong
fluoresc
specif
local
syncyti
nuclei
gonad
unbleach
bright
fluoresc
observ
h
inject
within
time
frame
vivo
given
mango
show
rigid
fluoresc
bind
target
molecul
fluorogen
aptam
work
vivo
model
optim
mango
expect
appear
vivo
mammalian
imag
rna
aptam
corn
activ
yellow
fluoresc
bind
dfho
develop
group
isol
spinach
broccoli
corn
show
improv
photost
compar
spinach
broccoli
enabl
quantifi
rna
transcript
live
cell
genet
encod
fluoresc
rna
report
corn
trna
ly
scaffold
express
three
main
subclass
pol
iii
promot
rna
trna
promot
transfect
report
plasmid
cell
led
yellow
fluoresc
addit
dfho
treatment
actinomycin
inhibitor
rna
polymeras
reduct
yellow
fluoresc
observ
although
corn
show
enhanc
photost
dimer
make
unsuit
imag
tag
cell
due
structur
chang
new
highbind
rna
mango
fluorogen
aptam
isol
base
microfluidicsbas
select
method
newli
isol
mango
show
bright
brighter
enhanc
green
fluoresc
protein
egfp
bound
target
small
molecul
test
cellular
imag
new
mangotag
rna
subcellular
local
two
small
noncod
rna
investig
mammalian
cell
imag
human
ribosom
rna
tag
new
mango
incorpor
fold
scaffold
vitrotranscrib
rna
transfect
cell
show
bright
rna
foci
per
cell
major
foci
cytoplasm
small
faction
nuclear
subcellular
local
studi
foci
overlap
mitochondria
subcellular
compart
pbodi
endosom
stress
granul
confirm
observ
specif
snrna
small
nuclear
rna
associ
ribonuclear
protein
snrnp
tag
new
mango
fold
scaffold
transfect
vitrotranscrib
rna
show
fold
increas
foci
nuclear
mainli
overlap
small
nuclear
protein
snrnp
mitochondria
ribosom
result
highlight
new
mango
tag
use
track
preferenti
cellular
locat
small
cellular
rna
function
genet
encod
tag
express
cell
plasmid
construct
express
rrna
rna
pol
iii
promot
pslq
plasmid
construct
exhibit
increas
fluoresc
signal
nucleolar
compart
well
cytoplasm
foci
demonstr
capabl
new
mango
tag
function
effici
genet
encod
report
rna
subcellular
local
limit
ribosom
protein
mitochondria
result
show
inconsist
coloc
compar
transfect
vitrotranscrib
rna
current
live
rna
imag
eukaryot
cell
big
challeng
fluoresc
aptam
due
main
issu
low
intens
rapid
photo
bleach
aptam
structur
chang
henc
literatur
shown
success
imag
mammalian
cell
comparison
fluorophor
ligand
bind
complex
stabil
studi
mango
larg
thermal
stabil
better
discrimin
broad
rang
small
molecul
corn
show
improv
photost
therefor
doubt
mango
corn
could
good
tool
elucid
work
mechan
cancer
biolog
field
viral
diseas
investig
viral
rna
dynam
full
cdna
sindbi
viru
sinv
construct
two
copi
trnascaffold
live
cell
imag
reveal
sinv
viral
rna
mainli
local
tip
filopodia
infect
cell
contact
adjac
noninfect
cell
later
viral
rna
observ
contact
site
uninfect
cell
spread
cytosol
studi
clearli
demonstr
fluorogen
aptam
tag
might
good
tool
investig
dynam
viral
rna
virolog
field
molecular
interact
live
cell
two
fluoresc
rna
aptam
spinach
mango
engin
use
rna
origami
scaffold
detect
conform
chang
call
aptamersbas
reson
energi
transfer
aptafret
obtain
fret
spinach
mango
place
close
proxim
scaffold
genet
encod
plasmid
aptafret
construct
express
e
coli
show
toler
fret
output
suggest
aptafret
system
might
use
realtim
imag
live
cell
biosensor
fluorogen
rna
aptam
spinach
broccoli
mango
corn
new
mango
power
tool
genet
encod
tag
gene
interest
livecel
imag
still
remain
issu
well
toler
engin
get
answer
one
studi
perform
well
fluorogen
rna
aptam
toler
engin
structur
cellular
rna
nine
distinct
variant
spinach
broccoli
insert
posit
ribosom
rna
rrna
compar
studi
among
nine
variant
babi
spinach
broccoli
yield
superior
fluoresc
livecel
imag
e
coli
howev
variant
spinach
broccoli
impair
cell
growth
depend
sequenc
length
aptam
show
toxic
henc
optim
indispens
strategi
describ
enabl
design
sensor
imag
essenti
molecul
live
cell
fluorogen
rna
aptam
tag
divers
applic
imag
intracellular
rna
dynam
fig
also
theoret
rna
aptam
readili
gener
biomolecul
new
fluorogen
aptam
expect
develop
sequencespecif
dnabind
protein
call
transcript
factor
tf
regul
transcript
activ
repress
play
critic
role
control
gene
express
live
organ
proof
concept
studi
rna
aptam
develop
target
tf
regul
gene
express
prokaryot
eukaryot
regul
gene
express
aptam
promis
therapeut
strategi
repres
exampl
gene
regul
aptam
depict
section
artifici
rna
aptam
promis
role
noncod
regulatori
rna
use
gene
regul
molecular
engin
last
decad
function
role
regulatori
rna
gene
express
well
develop
prokaryot
specif
transcript
activ
gene
express
aptam
e
coli
rna
aptam
bacteri
transcript
regul
tet
repressor
tetr
activ
transcript
modul
dnabind
activ
tetr
activ
intracellularli
express
tetr
aptam
directli
correl
express
level
stabil
group
isol
inhibitori
rna
aptam
repressor
protein
lambda
phage
ci
transcript
activ
e
coli
upon
intracellular
aptam
express
express
report
gene
increas
studi
illustr
valuabl
strategi
fine
regul
genet
circuit
use
synthet
rna
aptam
convent
artifici
aptam
isol
target
synthet
aptam
librari
pool
systemat
search
natur
rna
aptam
regul
transcript
direct
interact
rna
polymeras
rnap
bacteria
genom
selex
genom
librari
e
coli
sourc
rna
sequenc
e
coli
rnap
holoenzym
bait
perform
follow
nextgener
sequenc
function
analysi
natur
rna
aptam
rnap
rap
identifi
e
coli
genom
major
identifi
rap
character
inhibitori
rap
irap
encod
strand
opposit
annot
gene
act
like
transcript
antiinterfer
antisens
irap
curb
transcript
interfer
cisact
protermin
signal
potenti
express
senseencod
gene
studi
show
natur
rna
aptam
potenti
selfregulatori
system
robust
synthet
tool
use
control
cellular
gene
regul
proofofconcept
studi
ligandmedi
ribozym
cleavag
tetracyclin
tet
aptam
graft
hammerhead
ribozym
insert
untransl
region
utr
report
gene
work
mechan
ligand
bind
aptam
destroy
looploop
interact
within
ribozym
therebi
inhibit
ribozym
cleavag
allow
gene
express
function
assay
tetaptamerribozym
vector
transfect
hela
cell
cell
express
tetdepend
ribozym
show
increas
express
report
gene
fold
presenc
tet
absenc
proofof
principl
concept
condit
control
gene
express
tetaptamerribozym
success
establish
mammalian
cell
transcript
factor
tf
pivot
role
regul
gene
express
cell
growth
develop
cellular
homeostasi
therefor
dysregul
tf
link
mani
type
diseas
make
attract
target
therapeut
develop
sever
natur
prokaryot
eukaryot
rna
modul
activ
tf
rna
rna
hepat
delta
viru
rna
neuron
restrict
silenc
element
rna
growth
arrestspecif
alreadi
report
nucleic
acid
aptam
encod
transgen
endogen
express
transcriptionregul
aptam
uniqu
advantag
therapeut
henc
intrigu
concept
synthet
aptam
target
dnabind
tf
depict
emphasi
emerg
cancer
therapeut
transcript
factor
member
fork
head
wingedhelix
fox
famili
activ
network
proliferationassoci
gene
frequent
overexpress
cancer
contain
highli
conserv
dna
bind
domain
dbd
therefor
target
dbd
could
suppress
transcript
activ
present
potent
therapeut
strategi
cancer
dna
aptam
target
dbd
apt
isol
phosphorthioatemodifi
apt
apt
construct
increas
serum
stabil
apt
apt
show
specif
bind
protein
apt
improv
bind
affin
nm
nm
apt
local
nuclei
cell
transfect
test
inhibit
transcript
activ
vitro
gel
shift
assay
perform
abolish
bind
consensu
bind
site
dosedepend
manner
biolog
function
assay
apt
significantli
inhibit
cell
prolifer
h
time
point
treatment
treatment
apt
dramat
decreas
express
gene
cyclin
breast
cancer
cell
suggest
inhibitori
effect
result
disturb
transcript
activ
directli
affect
express
heat
shock
factor
tf
regul
chaperon
protein
express
cell
surviv
stress
condit
particularli
malign
cancer
aptam
isol
drosophila
protein
iarna
deliv
hela
cervic
carcinoma
cell
form
synthet
gene
contain
hammerhead
ribozym
iarna
express
induc
morpholog
chang
apoptosi
cervic
cancer
cell
normal
cell
show
cancer
specif
effect
level
variou
molecular
chaperon
protein
heat
shock
protein
calnexin
transglutaminas
glucoseregul
protein
also
significantli
decreas
aptamerexpress
cell
suggest
inhibit
molecular
chaperon
iarna
due
gener
decreas
activ
gene
target
transcript
factor
nfkb
import
activ
gene
involv
immun
function
inflamm
synthesi
cytokin
interferon
apoptosi
cancer
henc
inhibit
nfkb
depend
gene
activ
one
good
strategi
enhanc
activ
anticanc
drug
solubl
molecular
decoy
nfkb
rna
aptam
identifi
homodim
form
nfkb
vitro
assay
select
antinfkb
aptam
competit
inhibit
dna
bind
nfkb
follow
studi
perform
optim
rna
aptam
bind
nfkb
optim
antinfkb
aptam
demonstr
specif
decoy
activ
inhibit
transcript
activ
nfkb
target
protein
express
bival
antinfkb
aptam
decoy
activ
enhanc
studi
strong
implic
express
therapeut
decoy
rna
possibl
modul
gene
express
antinfkb
also
isol
group
parallel
select
antinfkb
aptam
similar
decoy
effect
competit
assay
henc
potenti
therapeut
strategi
combin
aptam
form
heterodimer
aptam
compet
simultan
bind
subunit
nfkb
heterodim
transcript
factor
import
regul
hematopoiesi
import
partner
leukemia
leukemia
therapeut
rna
aptam
isol
recombin
runthomologydomain
rhd
interact
partner
corebind
factor
protein
competit
experi
identifi
aptam
disrupt
format
complex
suggest
rna
aptam
could
act
molecular
dna
mimic
adopt
threedimension
structur
similar
physicochem
properti
cognat
rhd
dna
aptam
develop
cell
surfac
receptor
target
therapeut
deliveri
success
stori
well
construct
field
therapeut
develop
viral
diseas
cancer
rather
cell
surfac
receptor
aptam
intracellular
target
aptam
intram
depict
new
field
therapeut
develop
section
therapeut
intram
activ
develop
viral
protein
human
immunodefici
viru
hiv
tat
revers
transcriptas
hepat
c
viru
proteasehelicas
rnadepend
rna
polymeras
sever
acut
respiratori
syndrom
ntpasehelicas
mutat
virus
chang
structur
target
protein
nullifi
effect
antivir
drug
accordingli
antivir
drug
develop
move
toward
highli
conserv
target
viral
utr
region
singlestrand
rna
lentiviru
famili
retrovirida
genom
kb
multipl
open
read
frame
flank
utr
end
univers
antivir
effect
rna
aptam
isol
target
first
nt
highli
conserv
round
select
length
utr
aptam
isol
sequenc
analysi
hexanucleotid
within
antihiv
utr
aptam
found
complementari
apic
loop
poli
domain
repeat
region
r
locat
hiv
indic
hexanucleotid
sequenc
put
bind
site
use
silico
aptamerstarget
analysi
antihiv
utr
aptam
truncat
ntlong
stemloop
rna
aptam
includ
hexnucleotid
function
assay
unmodifi
fulllength
antihiv
utr
aptam
show
inhibitori
effect
transfect
chemic
synthes
show
inhibitori
effect
suggest
improv
halflif
pivot
follow
studi
full
length
antihiv
utr
aptam
clone
human
snrna
cassett
stabl
hairpinloop
domain
cell
transfect
vitro
transcrib
antihiv
utr
aptam
plasmid
inhibit
hiv
particl
product
upto
proteasom
critic
role
protein
homeostasi
regul
via
ubiquitin
ub
depend
proteolysi
protein
intrins
disord
ubproteasom
system
qualiti
control
mechan
one
proteasomeassoci
deubiquitin
enzym
ubiquitin
carboxyltermin
hydrolas
delet
small
molecul
inhibit
result
acceler
proteasom
degrad
variou
target
substrat
suggest
therapeut
target
treat
diseas
caus
accumul
damag
misfold
protein
neurodegen
diseas
one
studi
rna
aptam
isol
base
protein
selex
found
facilit
degrad
alzheim
diseaseimpl
tau
protein
via
enhanc
proteolyt
activ
proteom
inhibit
deubiquitin
activ
result
suggest
aptam
promis
therapeut
option
alzheim
diseas
extracellular
matrix
protein
periostin
secret
protein
function
cell
attach
protein
autocrin
paracrin
factor
signal
cell
adhes
molecul
v
v
integrin
pathophysiolog
involv
wound
repair
tumorigenesi
origin
antiperipstin
dna
aptam
develop
inhibit
breast
cancer
growth
metastasi
recent
accumul
evid
suggest
high
express
periostin
involv
renal
fibrosi
hyper
activ
transform
growth
pathway
inde
accumul
periostin
associ
progress
renal
fibrosi
diabet
nephropathi
activ
regard
one
main
mediat
deleteri
effect
diabet
nephropathi
determin
feasibl
antiperiostin
dna
aptam
therapeut
renal
fibrosi
diabet
nephropathi
biolog
function
antiperiostin
dna
aptam
determin
diabet
mellitu
anim
model
show
antiperiostin
dna
aptam
attenu
increas
blood
urea
nitrogen
level
express
fibronectin
tubul
interstiti
fibrosi
diabet
condit
vivo
suggest
antiperiostin
dna
aptam
might
potenti
therapeut
treat
fibrosi
diabet
periostin
also
promot
hepat
fibrosi
modul
hepat
stellat
cell
activ
via
v
integrin
interact
mice
henc
antiperiostin
dna
aptam
implic
applic
therapeut
treat
liver
fibrosi
identifi
cancer
specif
aptam
pivot
increas
therapeut
index
cancer
recent
develop
cancer
specif
aptam
target
cancer
plasma
membran
well
function
deliveri
therapeut
small
rna
small
molecul
antibodi
peptid
even
novel
cancer
specif
biomark
discoveri
rna
aptam
target
cancer
stem
cell
csc
surfac
marker
marker
epcam
prostat
csc
well
character
cancer
specif
therapeut
effect
along
aptam
cancer
specif
point
mutat
isotyp
attract
target
specif
anticanc
effect
herein
repres
cancer
specif
intram
depict
protein
singl
amino
acid
substitut
caus
plethora
human
diseas
also
point
mutat
multipl
tumor
suppressor
protein
caus
cancer
actual
human
cancer
relat
mutat
tumor
suppressor
singl
amino
acid
substitut
one
mutat
domin
mutat
mutat
abolish
function
wide
type
wt
confer
gain
antiapoptot
effect
lung
cancer
cell
select
specif
rna
aptam
contrast
screen
selex
use
wt
protein
rna
aptam
bind
wt
discard
rna
bind
select
recov
amplifi
five
round
selex
rna
aptam
bind
specif
success
isol
specif
bind
wt
confirm
gel
shift
assay
vitro
function
assay
intracellular
deliveri
aptam
nanoparticl
affect
cell
growth
harbor
wt
anoth
type
mutant
aptam
clearli
show
inhibit
cell
growth
harbor
lung
tumor
cell
xenograft
anim
model
mutant
harbor
tumor
cell
subcutan
inject
nude
mice
aptam
coat
nanoparticl
inject
two
time
day
day
subcutan
tumor
show
significantli
slower
lung
tumor
growth
induc
apoptosi
ubiquit
cellular
scaffold
protein
consid
attract
therapeut
target
role
signal
mediat
critic
tumorigenesi
pathway
two
isoform
share
high
sequenc
homolog
similar
structur
distinct
role
signal
genet
ablat
protect
anim
progress
myeloid
leukemia
therapeut
purpos
specif
rna
aptam
isol
counter
selex
aptam
show
high
bind
affin
fold
lower
bind
affin
intracellular
deliveri
strategi
dna
target
aptam
nucleolin
aptam
link
therapeut
aptam
aptam
complementari
base
pair
anneal
aptam
chimera
allow
deliv
intram
chronic
myelogen
leukemia
cell
without
viral
vector
transfect
agent
aptam
chimera
show
fulli
function
inhibit
signal
cascad
show
downregul
gli
consequ
aptam
chimera
inhibit
leukemia
cell
growth
coloni
form
assay
antitumor
effect
determin
vivo
translat
dysregul
increas
cellular
prolifer
prooncogen
mrna
hallmark
mani
cancer
mrna
hold
high
structur
requir
high
level
eukaryot
initi
factor
helicas
activ
effici
translat
recent
observ
increas
eukaryot
initi
factor
activ
breast
cancer
malign
also
prove
mrna
depend
activ
cellular
transform
make
attract
target
therapeut
intervent
inde
rna
aptam
character
use
proteinbas
selex
methodolog
vitro
function
assay
show
inhibit
capdepend
translat
block
atp
hydrolysi
work
mechan
aptam
propos
aptam
inhibit
conform
chang
necessari
atp
hydrolysi
base
fact
malign
cell
becom
addict
alter
translat
landscap
select
aptam
great
potenti
therapeut
type
malign
cancer
still
remain
challeng
intram
therapeut
option
deliveri
two
studi
clearli
show
success
deliveri
intram
cell
use
nanoparticl
aptam
henc
aptam
target
intracellular
antigen
promis
therapeut
field
expand
cancer
tradit
approach
studi
function
given
protein
live
cell
base
small
molecul
drug
exhibit
high
specif
affin
inhibitori
activ
major
aptam
show
inhibitori
protein
function
therefor
one
intrigu
idea
brought
aptamerprotein
complex
verifi
intracellular
function
use
develop
assay
screen
smallmolecul
librari
main
concept
displac
aptam
target
protein
releas
fluoresc
signal
small
molecul
compet
aptamerprotein
interact
highthroughput
screen
report
ribozym
develop
screen
member
sampl
librari
antibiot
molecul
could
disrupt
interact
hiv
rev
cognat
rna
small
molecul
compet
bind
site
aptamerprotein
complex
ribozym
becom
activ
cleav
substrat
label
fluoresc
tag
quencher
cleav
state
two
product
rapidli
dissoci
ribozym
result
fluoresc
signal
result
screen
identifi
one
compound
coumermycin
inhibit
viru
replic
cell
cultur
experi
proof
concept
studi
well
establish
novel
small
drug
inhibitor
screen
assay
use
interfer
aptamerprotein
interact
current
molecular
biolog
techniqu
limit
abil
distinguish
conform
chang
protein
aptam
superior
target
recognit
function
allow
us
use
tool
detect
conform
chang
target
protein
inde
compel
studi
investig
sophist
aptam
detect
conform
chang
affect
downstream
signal
gproteincoupl
receptor
gpcr
gpcr
transmembranespan
receptor
member
identifi
human
genom
gpcr
popular
target
pharmaceut
industri
onethird
pharmaceut
agent
target
gpcr
current
avail
market
treatment
variou
human
diseas
gpcr
undergo
conform
chang
activ
intracellular
signal
cascad
respons
agonist
bind
exhibit
conform
heterogen
ligandoccupi
ligandfre
state
take
full
advantag
aptam
high
target
recognit
detect
conform
chang
gpcr
bind
agonist
highli
divers
rna
librari
combin
nextgener
sequenc
bioinformat
analys
use
isol
rna
aptam
bound
prototyp
gpcr
selex
protein
produc
baculovirusmedi
express
spodoptera
frugiperda
insect
cell
keep
activ
conform
state
select
rna
aptam
agonist
use
result
sever
aptam
group
three
categori
conform
select
aptam
activ
form
bind
specif
aptam
inact
form
clear
select
aptam
bind
unoccupi
form
character
modul
transit
activ
inact
conform
well
stabil
ligandspecif
conform
explor
use
agonist
antagonist
invers
agonist
compar
control
aptam
robustli
bound
agonistoccupi
correl
agonist
efficaci
bind
markedli
reduc
presenc
antagonist
interestingli
aptam
correl
ligand
efficaci
invest
work
mechan
receptor
pulldown
assay
perform
surprisingli
aptam
display
uniqu
select
toward
conform
stabil
invers
agonist
suggest
aptam
stabil
uniqu
activ
conform
distinct
stabil
aptam
investig
abil
aptam
stabil
activ
conform
fluoresc
spectroscop
studi
decreas
fluoresc
intens
upon
conform
chang
perform
label
biman
probe
result
show
enhanc
effect
decreas
fluoresc
intens
combin
full
agonist
signifi
stabil
activ
conform
aptam
investig
bind
epitop
structur
basi
interact
neg
stain
electron
microscopi
em
singleparticl
reconstruct
analysi
util
visual
ar
complex
show
appear
interact
extracellular
region
receptor
contrari
bound
intracellular
region
suggest
bind
aptam
activ
state
ar
inhibit
receptor
presenc
agonist
engag
alloster
mechan
fig
indic
aptam
might
use
alloster
inhibit
report
relationship
bind
affin
function
effect
ar
aptam
studi
support
idea
bind
site
aptam
target
bind
affin
import
function
effect
heat
shock
protein
ubiquit
molecular
chaperon
play
critic
role
proteostasi
driven
atpas
activ
hold
two
conform
conformationspecif
rna
aptam
isol
aptam
inhibit
atpas
activ
atp
hydrolysi
increasingli
recogn
drug
target
number
age
relat
diseas
neurodegen
protein
misfold
diseas
cancer
specif
aptam
great
potenti
therapeut
applic
activ
famili
transcript
factor
consist
homodim
heterodim
jun
fo
regul
varieti
transcript
process
respons
stimuli
recogn
dna
bind
site
differ
homodim
heterodim
composit
jun
fo
show
promoterspecif
differ
transcript
activ
dimer
regul
variabl
cellular
pathway
includ
cell
prolifer
apoptosi
tumorigenesi
howev
current
molecular
biolog
techniqu
unabl
distinguish
differ
role
cjuncjun
homodim
versu
cjuncfo
heterodim
build
foundat
investig
differ
dimer
composit
dna
aptam
isol
use
cjun
homodim
protein
base
selex
bind
specif
dna
aptam
homodim
cjuncjun
cjun
cfo
heterodim
confirm
gel
shift
assay
competit
assay
anticjun
aptam
block
homodimer
cjun
bind
dna
cjun
homodim
capabl
bind
cisel
dna
activ
transcript
also
function
transcript
coactiv
bind
directli
transcript
factor
synergist
activ
interleukin
therefor
determin
biolog
function
anticjun
homodim
dna
aptam
transcript
inhibit
assay
anticjun
dimer
aptam
repress
express
luciferas
assay
fig
specif
aptam
reflect
arrang
loop
stem
hydrogen
bond
stabil
threedimension
structur
structur
stabil
aptam
reli
core
form
stack
gquadruplex
gquadruplex
guaninerich
sequenc
extrem
stabl
secondari
structur
gquadruplex
form
guanin
organ
planar
quartet
base
connect
two
base
via
hoogsteen
base
pair
hydrogen
bond
pair
guanin
involv
four
donoracceptor
atom
gquadruplex
eight
hydrogen
bond
total
howev
case
stabl
gquadruplex
aptam
shown
crossbind
sever
differ
protein
exampl
gquadruplex
dna
aptam
bind
hivintegras
gquadruplex
rna
aptam
show
crossbind
pdgfaa
pdgfbb
structur
stabil
aptam
mainli
via
gquadruplex
format
import
may
reduc
specif
aptam
case
thu
gquadruplex
requir
aptam
stabil
consid
doubleedg
sword
recent
concern
regard
potenti
immun
stimul
synthet
dna
aptam
human
blood
rais
avoid
immun
stimul
numer
type
nonnatur
chemic
modif
develop
function
divers
dna
xenonucl
acid
xna
artifici
genet
polym
rna
current
wide
use
chemic
modif
rna
aptam
investig
immun
respons
chemicallymodifi
rna
aptam
vitro
level
nucleotid
incorpor
rna
aptam
modif
abrog
stimul
tolllik
receptor
enhanc
activ
retino
acidinduc
gene
modif
triphosph
increas
cell
death
express
human
cancer
cell
compar
hydroxyl
wherea
chemic
synthes
rna
aptam
without
interestingli
replac
rna
aptam
complet
abolish
express
inflammatori
cytokin
suggest
main
immun
respons
rna
aptam
due
commonli
use
chemic
modif
selex
vitro
transcript
inde
gener
rna
aptam
selex
unavoid
henc
avoid
immun
respons
first
selex
chemic
synthes
aptam
use
rna
aptam
specif
recogn
activ
state
act
alloster
modul
gproteincoupl
receptor
gpcr
bind
distinct
site
inhibit
signal
activ
b
homodimerrecogn
aptam
dna
aptam
specif
bind
cjuncjun
compar
cjuncfo
block
bind
transcript
factor
activ
protein
dna
element
inhibit
cjun
homodim
transcript
cell
vivo
assay
clinic
trial
second
modif
might
consid
selex
unfortun
current
avail
polymeras
incorpor
selex
increas
pharmacokinet
pegyl
aptam
often
use
strategi
clinic
trial
pegnivacogin
pegyl
anticoagul
factor
ixa
rna
aptam
advers
immun
respons
found
later
discov
report
sever
allerg
reaction
due
preexist
antibodi
peg
past
decad
great
effort
made
investig
endocyt
mechan
aptam
subcellular
distribut
molecular
cellular
level
main
endocyt
mechan
aptam
categor
clathrindepend
independ
depend
type
target
cell
variat
intracellular
distribut
also
observ
depend
type
cell
upon
bind
aptam
intracellular
target
antagonist
aptam
induc
altern
intracellular
distribut
target
inhibit
biolog
function
suggest
potenti
intracellular
therapeut
applic
inde
excit
improv
intracellular
aptam
intram
develop
gene
regul
aptam
antitf
aptam
therapeut
conform
specif
aptam
alloster
inhibitor
cancer
howev
spite
great
achiev
therapeut
intram
translat
clinic
slow
henc
facilit
success
translat
therapeut
intram
strategi
consid
first
improv
endosom
escap
describ
intern
aptam
local
endosom
lysosom
biolog
activ
aptam
must
reach
cytosol
escap
endosom
aptam
endocytos
via
receptormedi
clathrindepend
mechan
rate
access
cytosol
mainli
depend
express
receptor
rate
receptor
recycl
endosom
escap
effici
typic
small
percentag
endocytos
nucleic
acidbas
therapeut
abl
escap
endosom
henc
facilit
endosom
escap
pivot
increas
efficaci
therapeut
intram
improv
endosom
escap
current
avail
endosom
escap
aid
smallmolecul
endosomolyt
agent
chloroquin
emerg
altern
improv
endosom
escap
conjug
endosomolyt
peptid
directli
rna
molecul
exampl
antipmsa
aptamersirna
chimera
conjug
phdepend
polyhistidin
tag
shown
remark
effect
endosom
destabil
improv
gene
silenc
effect
chimera
fig
thu
conjug
aptam
tissuepenetr
endosom
escap
peptid
facilit
translat
therapeut
intram
clinic
second
transcriptionactiv
aptam
therapeut
aptamermedi
target
tf
emerg
approach
suppress
intract
protein
target
far
transcriptionactiv
aptam
mainli
develop
e
coli
mammalian
cell
transcript
activ
target
transcript
cofactor
aptam
could
lead
remark
efficaci
surprisingli
littl
toxic
normal
tissu
therefor
membranebound
transcript
factor
notch
also
excel
target
develop
therapeut
aptam
third
function
chang
truncat
aptam
recent
emerg
major
issu
function
chang
aptam
truncat
instanc
ampa
kainit
receptor
differ
subtyp
glutam
ion
channel
one
group
found
fulllength
aptam
block
ampa
receptor
specif
truncat
version
aptam
equal
inhibit
ampa
kainit
receptor
suggest
aptam
could
serv
multipl
function
truncat
even
though
dual
function
aptam
might
clinic
benefici
function
structur
chang
aptam
truncat
care
investig
